CD73 Is a Critical Immune Checkpoint in a Molecular Subtype of Pancreatic Cancer

被引：1
作者：
DelGiorno, Kathleen [1 ,2 ,3 ,4 ]
机构：
[1] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Med Ctr, Vanderbilt Digest Dis Res Ctr, Nashville, TN 37232 USA
[3] Vanderbilt Ingram Canc Ctr, Nashville, TN USA
[4] Vanderbilt Univ, Sch Med, Cell & Dev Biol, 465 21st Ave South, Nashville, TN 37232 USA
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
CELL;
D O I：
10.1158/0008-5472.CAN-23-0268
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：977 / 978
页数：2
相关论文
共 10 条
  • [1] Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma
    Aguirre, Andrew J.
    Hruban, Ralph H.
    Raphael, Benjamin J.
    [J]. CANCER CELL, 2017, 32 (02) : 185 - +
  • [2] CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer
    Faraoni, Erika Y.
    Singh, Kanchan
    Chandra, Vidhi
    Le Roux, Olivereen
    Dai, Yulin
    Sahin, Ismet
    O'Brien, Baylee J.
    Strickland, Lincoln N.
    Li, Le
    Vucic, Emily
    Warner, Amanda N.
    Pruski, Melissa
    Clark, Trent
    Van Buren, George
    Thosani, Nirav C.
    Bynon, John S.
    Wray, Curtis J.
    Bar-Sagi, Dafna
    Poulsen, Kyle L.
    Vornik, Lana A.
    Savage, Michelle I.
    Sei, Shizuko
    Mohammed, Altaf
    Zhao, Zhongming
    Brown, Powel H.
    Mills, Tingting
    Eltzschig, Holger K.
    McAllister, Florencia
    Bailey-Lundberg, Jennifer M.
    [J]. CANCER RESEARCH, 2023, 83 (07) : 1111 - 1127
  • [3] Purinergic and Adenosinergic Signaling in Pancreatobiliary Diseases
    Faraoni, Erika Y.
    Ju, Cynthia
    Robson, Simon C.
    Eltzschig, Holger K.
    Bailey-Lundberg, Jennifer M.
    [J]. FRONTIERS IN PHYSIOLOGY, 2022, 13
  • [4] Cell of Origin Influences Pancreatic Cancer Subtype
    Flowers, Brittany M.
    Xu, Hang
    Mulligan, Abigail S.
    Hanson, Kathryn J.
    Seoane, Jose A.
    Vogel, Hannes
    Curtis, Christina
    Wood, Laura D.
    Attardi, Laura D.
    [J]. CANCER DISCOVERY, 2021, 11 (03) : 660 - 677
  • [5] Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment
    Hwang, William L.
    Jagadeesh, Karthik A.
    Guo, Jimmy A.
    Hoffman, Hannah, I
    Yadollahpour, Payman
    Reeves, Jason W.
    Mohan, Rahul
    Drokhlyansky, Eugene
    Van Wittenberghe, Nicholas
    Ashenberg, Orr
    Farhi, Samouil L.
    Schapiro, Denis
    Divakar, Prajan
    Miller, Eric
    Zollinger, Daniel R.
    Eng, George
    Schenkel, Jason M.
    Su, Jennifer
    Shiau, Carina
    Yu, Patrick
    Freed-Pastor, William A.
    Abbondanza, Domenic
    Mehta, Arnav
    Gould, Joshua
    Lambden, Conner
    Porter, Caroline B. M.
    Tsankov, Alexander
    Dionne, Danielle
    Waldman, Julia
    Cuoco, Michael S.
    Lan Nguyen
    Delorey, Toni
    Phillips, Devan
    Barth, Jaimie L.
    Kem, Marina
    Rodrigues, Clifton
    Ciprani, Debora
    Roldan, Jorge
    Zelga, Piotr
    Jorgji, Vjola
    Chen, Jonathan H.
    Ely, Zackery
    Zhao, Daniel
    Fuhrman, Kit
    Fropf, Robin
    Beechem, Joseph M.
    Loeffler, Jay S.
    Ryan, David P.
    Weekes, Colin D.
    Ferrone, Cristina R.
    [J]. NATURE GENETICS, 2022, 54 (08) : 1178 - +
  • [6] Immune cell regulation by autocrine purinergic signalling
    Junger, Wolfgang G.
    [J]. NATURE REVIEWS IMMUNOLOGY, 2011, 11 (03) : 201 - 212
  • [7] CD73 induces GM-CSF/MDSC-mediated suppression of T cells to accelerate pancreatic cancer pathogenesis
    King, Ryan J.
    Shukla, Surendra K.
    He, Chunbo
    Vernucci, Enza
    Thakur, Ravi
    Attri, Kuldeep S.
    Dasgupta, Aneesha
    Chaika, Nina V.
    Mulder, Scott E.
    Abrego, Jaime
    Murthy, Divya
    Gunda, Venugopal
    Pacheco, Camila G.
    Grandgenett, Paul M.
    Lazenby, Audrey J.
    Hollingsworth, Michael A.
    Yu, Fang
    Mehla, Kamiya
    Singh, Pankaj K.
    [J]. ONCOGENE, 2022, 41 (07) : 971 - 982
  • [8] Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma: A Phase 2 Randomized Clinical Trial
    O'Reilly, Eileen M.
    Oh, Do-Youn
    Dhani, Neesha
    Renouf, Daniel J.
    Lee, Myung Ah
    Sun, Weijing
    Fisher, George
    Hezel, Aram
    Chang, Shao-Chun
    Vlahovic, Gordana
    Takahashi, Osamu
    Yang, Yin
    Fitts, David
    Philip, Philip Agop
    [J]. JAMA ONCOLOGY, 2019, 5 (10) : 1431 - 1438
  • [9] Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
    Rahib, Lola
    Smith, Benjamin D.
    Aizenberg, Rhonda
    Rosenzweig, Allison B.
    Fleshman, Julie M.
    Matrisian, Lynn M.
    [J]. CANCER RESEARCH, 2014, 74 (11) : 2913 - 2921
  • [10] Targeting immunosuppressive adenosine in cancer
    Vijayan, D.
    Young, Arabella
    Teng, Michele W. L.
    Smyth, Mark J.
    [J]. NATURE REVIEWS CANCER, 2017, 17 (12) : 709 - +
1